Menthol Ban for Tobacco Use

RAND, Pittsburgh, PA
Tobacco UseMenthol Ban - Other
Eligibility
11 - 17
All Sexes
What conditions do you have?
Select

Study Summary

This trial will be testing if getting rid of flavored tobacco products at stores will reduce the risk of adolescents smoking.

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: There is one visit in this research: This variable is assessed at that visit, immediately after the experimental manipulation.

There is one visit in this research: This variable is assessed at that visit, immediately after the experimental manipulation.
Self-reported cigarette smoking risk after shopping in the StoreLab
Self-reported cigarillo use risk
Self-reported smokeless tobacco use risk
Self-reported vaping/ENDDS risk of use

Trial Safety

Side Effects for

ANTI-ANGIN® FORMULA (Arm B)
3%Oral discomfort
2%Headache
1%Heart rate increased
1%Dysphonia
1%Radius fracture
1%Diarrhea
1%Vomiting
1%Nasal dryness
1%Cough
1%Abdominal pain upper
This histogram enumerates side effects from a completed 2017 Phase 3 trial (NCT03095508) in the ANTI-ANGIN® FORMULA (Arm B) ARM group. Side effects include: Oral discomfort with 3%, Headache with 2%, Heart rate increased with 1%, Dysphonia with 1%, Radius fracture with 1%.

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

3 Treatment Groups

Status Quo
1 of 3
Flavors Banned
1 of 3
Flavors and Menthol Banned
1 of 3

Active Control

Experimental Treatment

900 Total Participants · 3 Treatment Groups

Primary Treatment: Menthol Ban · No Placebo Group · N/A

Flavors Banned
Other
Experimental Group · 1 Intervention: Flavor Ban · Intervention Types: Other
Flavors and Menthol BannedExperimental Group · 2 Interventions: Menthol Ban, Flavor Ban · Intervention Types: Other, Other
Status Quo
Other
ActiveComparator Group · 1 Intervention: All flavored and mentholated products available · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: there is one visit in this research: this variable is assessed at that visit, immediately after the experimental manipulation.

Who is running the clinical trial?

RANDLead Sponsor
128 Previous Clinical Trials
499,795 Total Patients Enrolled
2 Trials studying Tobacco Use
1,350 Patients Enrolled for Tobacco Use
William G Shadel, PhDPrincipal InvestigatorRAND

Eligibility Criteria

Age 11 - 17 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is enrollment still open for this clinical research study?

"This trial is recruiting up to 900 juvenile individuals, aged 11-17, who have a history of tobacco use. To join the study, minors need parental permission and their own assent." - Anonymous Online Contributor

Unverified Answer

Is the age threshold for participation in this experiment set beyond eighty-five years?

"The youngest possible participant in this clinical trial is 11 years old, while the eldest must be no older than 17." - Anonymous Online Contributor

Unverified Answer

Are there any slots still available to join this experiment?

"According to the data published on clinicaltrials.gov, this investigation is presently recruiting patients. The trail was initially made available on January 16th 2020 before being revised most recently on February 14th 2022." - Anonymous Online Contributor

Unverified Answer

How extensive is the patient population currently enrolled in this clinical study?

"Affirmative. The details of this trial, which were initially posted on January 16th 2020, can be found on clinicaltrials.gov and suggest that the study is actively recruiting participants. Approximately 900 individuals are being sought out at a single site for participation in the trial." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.